CDK inhibitor LY2835219, Purity ≥98%

Cat. No.: X24-05-ZQ748

CDK inhibitor LY2835219, Purity ≥98%

Synonym: 1231929-97-7; LY 2835219; LY-2835219; Abemaciclib; CDK inhibitor

  • CAS Number: 1231929-97-7
  • Compound CID: 46220502
Product Size
5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
LY2835219, soluble in DMSO and ethanol and insoluble in water, is an CDK kinase inhibitor that disrupts cell division processes. It targets CDK1/cyclinB1, CDK2/cyclinE, Cdk4/cyclin D1, and Cdk5/p25.
Molecular Weight
506.59
Molecular Formula
C27H32F2N8
Targets
CDK1/cyclinB1: 1627 nM; CDK2/cyclinE: 504 nM; Cdk4/cyclin D1: 2 nM; Cdk5/p25: 355 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 6 mg/mL (11.84 mM); Water: Insoluble; Ethanol: 8 mg/mL (15.79 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
LY2835219 (Abemaciclib) can be used to study the targeted inhibition of CDK4/6 in cancer therapies.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.